| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |